Isoprenaline

Generic Name
Isoprenaline
Brand Names
Isuprel
Drug Type
Small Molecule
Chemical Formula
C11H17NO3
CAS Number
7683-59-2
Unique Ingredient Identifier
L628TT009W
Background

Isoprenaline is a non-selective beta adrenergic receptor agonist indicated to treat heart block, Adams-Stokes attacks, bronchospasm in anesthesia, cadiac arrest, hypovolemic shocks, septic shock, hypoperfusion, congestive hear failure, and cardiogenic shock.
...

Indication

Isoprenaline is indicated to treat mild or transient episodes of heart block not requiring electric shock or pacemakers, serious episodes of heart block and Adams-Stokes attacks not caused by ventricular tachycardia or fibrillation, and bronchospasm during anesthesia. Isoprenaline is also indicated for cases of cardiac arrest until preferable treatments like...

Associated Conditions
Adams-Stokes attacks, Bradycardia, Bronchospasm, Cardiac Arrest, Cardiac electrical storm, Congestive Heart Failure (CHF), Hypoperfusion, Septic Shock, Serious Heart Block, Shock, Cardiogenic, Shock, Hypovolemic, Short QT syndrome, Syncope, Torsades de Pointes, Transient Heart Block, Ventricular Arrhythmia, Beta blocker overdose, Mild Heart Block
Associated Therapies
-
Clinical Trials
Related News

Exercise as an Immune Adjuvant for Allogeneic Cell Therapies

First Posted Date
2024-10-16
Last Posted Date
2024-10-16
Lead Sponsor
University of Arizona
Target Recruit Count
100
Registration Number
NCT06643221
Locations
🇺🇸

The University of Arizona, Tucson, Arizona, United States

Early Neurovascular Adaptations in Aging Women

First Posted Date
2024-07-25
Last Posted Date
2024-10-01
Lead Sponsor
University of Missouri-Columbia
Target Recruit Count
64
Registration Number
NCT06520982
Locations
🇺🇸

University of Missouri-Columbia, Columbia, Missouri, United States

Sex Disparities in Hypoxic Vasodilation and Impact of Obesity

First Posted Date
2022-02-02
Last Posted Date
2024-02-20
Lead Sponsor
University of Missouri-Columbia
Target Recruit Count
72
Registration Number
NCT05219799
Locations
🇺🇸

University of Missouri, Columbia, Missouri, United States

Adenosine to Assess Complete Conduction Block During Catheter Ablation of Paroxysmal Atrial Fibrillation

Phase 2
Completed
Conditions
Atrial Fibrillation
Interventions
Drug: Adenosine
Drug: Isoproterenol
First Posted Date
2017-01-26
Last Posted Date
2017-12-13
Lead Sponsor
University of Michigan
Target Recruit Count
131
Registration Number
NCT03032965
Locations
🇺🇸

University of Michigan, Ann Arbor, Michigan, United States

Augmented Interoceptive Exposure Training in Anorexia Nervosa

Not Applicable
Active, not recruiting
Conditions
Anorexia Nervosa
Interventions
Other: placebo
Drug: Isoproterenol
First Posted Date
2017-01-12
Last Posted Date
2023-10-05
Lead Sponsor
Laureate Institute for Brain Research, Inc.
Target Recruit Count
25
Registration Number
NCT03019081
Locations
🇺🇸

Laureate Institute for Brain Research, Tulsa, Oklahoma, United States

Decision Support for Intraoperative Low Blood Pressure

Not Applicable
Completed
Conditions
Hypotension
Interventions
Procedure: Attending real-time decision support
Procedure: In-room real-time decision support
Procedure: Attending feedback emails
Procedure: In-room provider feedback emails
Device: Anesthesia Information Management System (AIMS)
Device: Perioperative Data Warehouse (PDW)
Procedure: General anesthesia
Device: Pager system
Procedure: Central neuraxial anesthesia
Procedure: Non-cardiac surgery
Drug: Propofol
Drug: Sevoflurane
Drug: Desflurane
Drug: Isoflurane
Drug: Ephedrine
Drug: Phenylephrine
Drug: Norepinephrine
Drug: Epinephrine
Drug: Dobutamine
Drug: Dopamine
Drug: Isoproterenol
Drug: Milrinone
Drug: Atropine
Drug: Glycopyrrolate
Drug: Vasopressin
Drug: Terlipressin
Drug: Sodium Chloride 0.9%
Drug: Ringer's lactate
Drug: Hydroxyethyl starch solutions
Drug: Fresh Frozen Plasma
Drug: Packed Red Blood Cells
Drug: Albumin solutions
Drug: Plasma-Lyte
Drug: Lidocaine
Drug: Bupivacaine
Drug: Levobupivacaine
Drug: Ropivacaine
Drug: Mepivacaine
Drug: Tetracaine
Drug: Prilocaine
Drug: Procaine
Drug: Chloroprocaine
Drug: Benzocaine
Drug: Articaine
First Posted Date
2016-04-04
Last Posted Date
2019-05-16
Lead Sponsor
Vanderbilt University Medical Center
Target Recruit Count
22435
Registration Number
NCT02726620
Locations
🇺🇸

Vanderbilt University Medical Center, Nashville, Tennessee, United States

Autoimmune Basis for Postural Tachycardia Syndrome

First Posted Date
2016-03-31
Last Posted Date
2024-11-06
Lead Sponsor
Vanderbilt University Medical Center
Target Recruit Count
58
Registration Number
NCT02725060
Locations
🇺🇸

Autonomic Dysfunction Center, Nashville, Tennessee, United States

🇺🇸

University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States

POTS Adrenergic Ab (CIHR Aims #1&2)

First Posted Date
2016-02-04
Last Posted Date
2024-05-08
Lead Sponsor
University of Calgary
Target Recruit Count
125
Registration Number
NCT02673996
Locations
🇨🇦

University of Calgary, Calgary, Alberta, Canada

Neural Basis of Meal Related Interoceptive Dysfunction in Anorexia Nervosa

First Posted Date
2015-11-26
Last Posted Date
2023-11-18
Lead Sponsor
Laureate Institute for Brain Research, Inc.
Target Recruit Count
97
Registration Number
NCT02615119
Locations
🇺🇸

Laureate Institute for Brain Research, Tulsa, Oklahoma, United States

Chronotropic Incompetence in Patients With HFpEF

First Posted Date
2015-08-14
Last Posted Date
2020-08-06
Lead Sponsor
University of Texas Southwestern Medical Center
Target Recruit Count
40
Registration Number
NCT02524145
Locations
🇺🇸

The Institute for Exercise and Environmental Medicine, Dallas, Texas, United States

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy